Cerus Total Assets 2006-2018 | CERS

Cerus total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
Cerus Annual Total Assets
(Millions of US $)
2018 $163
2017 $98
2016 $103
2015 $139
2014 $82
2013 $83
2012 $49
2011 $45
2010 $48
2009 $34
2008 $47
2007 $78
2006 $116
2005 $59
Cerus Quarterly Total Assets
(Millions of US $)
Q4 2018 $163
Q3 2018 $162
Q2 2018 $152
Q1 2018 $144
Q4 2017 $98
Q3 2017 $97
Q2 2017 $83
Q1 2017 $85
Q4 2016 $103
Q3 2016 $116
Q2 2016 $120
Q1 2016 $128
Q4 2015 $139
Q3 2015 $135
Q2 2015 $151
Q1 2015 $143
Q4 2014 $82
Q3 2014 $79
Q2 2014 $77
Q1 2014 $73
Q4 2013 $83
Q3 2013 $79
Q2 2013 $83
Q1 2013 $92
Q4 2012 $49
Q3 2012 $49
Q2 2012 $46
Q1 2012 $52
Q4 2011 $45
Q3 2011 $37
Q2 2011 $39
Q1 2011 $46
Q4 2010 $48
Q3 2010 $32
Q2 2010 $30
Q1 2010 $32
Q4 2009 $34
Q3 2009 $43
Q2 2009 $35
Q1 2009 $39
Q4 2008 $47
Q3 2008 $52
Q2 2008 $64
Q1 2008 $70
Q4 2007 $78
Q3 2007 $85
Q2 2007 $92
Q1 2007 $106
Q4 2006 $116
Q3 2006 $89
Q2 2006 $91
Q1 2006 $100
Q4 2005 $59
Q3 2005 $57
Q2 2005 $59
Q1 2005 $63
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.823B $0.061B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $137.198B 26.75
Medtronic (MDT) Ireland $116.492B 17.03
Stryker (SYK) United States $69.834B 24.92
Boston Scientific (BSX) United States $51.351B 24.62
Baxter (BAX) United States $38.973B 24.52
Zimmer Biomet Holdings (ZBH) United States $25.515B 16.33
Smith & Nephew SNATS (SNN) United Kingdom $16.913B 0.00
Canopy Growth (CGC) Canada $16.587B 0.00
ResMed (RMD) United States $14.652B 27.78
Aurora Cannabis (ACB) Canada $9.189B 64.79
Bio-Rad Laboratories (BIO) United States $8.907B 51.09
Perrigo (PRGO) Ireland $6.811B 11.04
Hill-Rom Holdings (HRC) United States $6.475B 20.03
Insulet (PODD) United States $4.964B 1664.00
GW Pharmaceuticals (GWPH) United Kingdom $4.900B 0.00
ICU Medical (ICUI) United States $4.648B 28.79
Haemonetics (HAE) United States $4.345B 38.54
Hutchison China MediTech (HCM) China $3.899B 0.00
Agios Pharmaceuticals (AGIO) United States $3.354B 0.00
NuVasive (NUVA) United States $3.069B 26.66
Neogen (NEOG) United States $3.016B 49.04
Quidel (QDEL) United States $2.490B 22.28
National Vision Holdings (EYE) United States $2.281B 44.86
Aphria (APHA) $1.919B 0.00
HEXO (HEXO) $1.510B 0.00
Phibro Animal Health (PAHC) United States $1.352B 19.44
Cardiovascular Systems (CSII) United States $1.222B 877.50
VAREX IMAGING (VREX) United States $1.214B 23.77
AtriCure (ATRC) United States $1.089B 0.00
Lantheus Holdings (LNTH) United States $0.960B 25.95
Omeros (OMER) United States $0.920B 0.00
PetIQ (PETQ) United States $0.871B 24.92
MacroGenics (MGNX) United States $0.813B 0.00
NanoString Technologies (NSTG) United States $0.787B 0.00
Evolus (EOLS) United States $0.756B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.734B 24.99
TG Therapeutics (TGTX) United States $0.712B 0.00
OraSure Technologies (OSUR) United States $0.591B 25.76
LeMaitre Vascular (LMAT) United States $0.569B 27.03
Surmodics (SRDX) United States $0.567B 82.39
Meridian Bioscience (VIVO) United States $0.550B 16.38
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.320B 0.00
Utah Medical Products (UTMD) United States $0.317B 21.92
Insys Therapeutics (INSY) United States $0.314B 0.00
BioLife Solutions (BLFS) United States $0.308B 127.08
Vapotherm (VAPO) United States $0.293B 0.00
Rockwell Medical (RMTI) United States $0.267B 0.00
Cytosorbents (CTSO) United States $0.229B 0.00
Owens & Minor (OMI) United States $0.216B 2.96
Zynex (ZYXI) United States $0.174B 18.59
Bovie Medical (APYX) United States $0.161B 0.00
Fonar (FONR) United States $0.130B 6.96
Chimerix (CMRX) United States $0.129B 0.00
Chembio Diagnostics (CEMI) United States $0.125B 0.00
Surface Oncology (SURF) United States $0.112B 0.00
United-Guardian (UG) United States $0.089B 20.32
InfuSystems Holdings (INFU) United States $0.086B 0.00
Female Health (VERU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.79
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.023B 0.00
Myomo (MYO) United States $0.020B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.006B 5.87